The Europe Cementless Total Knee Arthroplasty Market would witness market growth of 5.2% CAGR during the forecast period (2023-2030).
The creation of cutting-edge materials as well as surface technologies is becoming increasingly important in cementless TKA. Innovations that support osseointegration and lengthen the life of the implant include the incorporation of titanium alloys and specific coatings like hydroxyapatite. Improved patient outcomes result from these developments, improving implant function and lowering the possibility of implant loosening. One of the main factors influencing product demand is orthopedic diseases like osteoarthritis in the elderly population.
The progression of RA varies widely, ranging from a moderate, even self-limiting condition to a severe, destructive variety. Total knee arthroplasty, which has recently undergone advances, has been used on several patients to reduce knee joint discomfort and restore function, with positive follow-up outcomes. Total knee arthroplasty utilizing a cemented approach has been advised for patients with rheumatoid arthritis due to the initial sturdiness of the fixation as well as the long-term durability of the components. Similar long-term follow-up outcomes have been noted in patients who underwent cementless TKA.
The aging population is a significant concern for the region and one of the most important factors propelling the demand for regenerative medicines. Among elderly people, osteoarthritis is the most prevalent type of arthritis. Additionally, it is among adults' most typical causes of physical impairment. Moreover, the prevalence of rheumatoid arthritis also differs between countries, noticeably increasing from southern to northern regions, according to the National Library of Medicine: 0.8% in Finland, 0.8% in Italy, and 0.85% in England. These elements, notably in the R&D industries, fuel the expansion of the healthcare infrastructure. Therefore, in the coming years, the growing proportion of aged people in the region will drive the expansion of the market.
The Germany market dominated the Europe Cementless Total Knee Arthroplasty Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $179.9 Million by 2030. The UK market is exhibiting a CAGR of 4.3% during (2023 - 2030). Additionally, The France market would experience a CAGR of 5.9% during (2023 - 2030).
Based on Product, the market is segmented into Fixed Bearing, and Mobile Bearing. Based on End User, the market is segmented into Hospitals, and Others. Based on Material, the market is segmented into Alloys, Ceramics, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Cementless total knee arthroplasty Market is Projected to reach USD 2.8 Billion by 2030, at a CAGR of 5.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, B. Braun Melsungen AG, Smith & Nephew PLC, Stryker Corporation, Olympus Corporation, Zimmer Biomet Holdings, Inc., MicroPort Scientific Corporation, United Orthopedic Corporation (Chi-Yi Investment Co. Ltd.), X.NOV and Waldemar Link GmbH & Co. KG.
By Product
By End User
By Material
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
